We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIM icon
876
Invesco Value Municipal Income Trust
IIM
$600M
$3.08M 0.02%
186,628
+76,216
+69% +$1.23M
UTF icon
877
Cohen & Steers Infrastructure Fund
UTF
$3.05B
$3.08M 0.02%
107,207
-82,784
-44% -$2.38M
BHP icon
878
BHP
BHP
$230B
$3.07M 0.02%
47,327
+3,450
+8% +$228K
DAR icon
879
Darling Ingredients
DAR
$9.59B
$3.05M 0.02%
45,245
-825
-2% -$58.1K
NMCO icon
880
Nuveen Municipal Credit Opportunities Fund
NMCO
$585M
$3.05M 0.02%
197,942
+123,021
+164% +$1.83M
NLY icon
881
Annaly Capital Management
NLY
$17.5B
$3.02M 0.02%
85,016
+24,011
+39% +$872K
ADPT icon
882
Adaptive Biotechnologies
ADPT
$3.92B
$3.02M 0.02%
73,866
+810
+1% +$31.5K
ZLAB icon
883
Zai Lab
ZLAB
$2.64B
$3.02M 0.02%
+17,046
New +$2.74M
BTA
884
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$3.01M 0.02%
221,464
+77,727
+54% +$1.03M
SRPT icon
885
Sarepta Therapeutics
SRPT
$1.77B
$3.01M 0.02%
38,756
-2,890
-7% -$219K
CNO icon
886
CNO Financial Group
CNO
$5.1B
$3M 0.02%
127,181
-16,853
-12% -$431K
BP icon
887
BP
BP
$108B
$3M 0.02%
113,641
+31,530
+38% +$827K
JHG
888
DELISTED
Janus Henderson
JHG
$3M 0.02%
77,301
-9,799
-11% -$356K
IGD
889
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$515M
$2.99M 0.02%
501,311
-13,463
-3% -$79.6K
OGN icon
890
Organon & Co
OGN
$3.56B
$2.98M 0.02%
+98,640
New +$3.25M
FICO icon
891
Fair Isaac
FICO
$22.5B
$2.98M 0.02%
5,935
+629
+12% +$318K
MHI
892
DELISTED
Pioneer Municipal High Income Fund
MHI
$2.98M 0.02%
229,598
-4,383
-2% -$55.7K
DRI icon
893
Darden Restaurants
DRI
$24.5B
$2.98M 0.02%
20,402
+7,668
+60% +$1.08M
SSRM icon
894
SSR Mining
SSRM
$6.38B
$2.95M 0.02%
189,480
-11,109
-6% -$187K
ONC
895
BeOne Medicines Ltd
ONC
$38.4B
$2.95M 0.02%
8,603
+677
+9% +$224K
ARNA
896
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.94M 0.02%
43,165
+2,176
+5% +$142K
VGI
897
Virtus Global Multi-Sector Income Fund
VGI
$82.9M
$2.94M 0.02%
246,234
+2,166
+0.9% +$26.2K
AGI icon
898
Alamos Gold
AGI
$13.8B
$2.94M 0.02%
383,944
+27,843
+8% +$238K
COR icon
899
Cencora
COR
$61.6B
$2.94M 0.02%
25,642
+4,303
+20% +$508K
AFB
900
AllianceBernstein National Municipal Income Fund
AFB
$317M
$2.92M 0.02%
191,948
+29,459
+18% +$432K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.